Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • Oxford Nanopore Outlook 2018

    Omics! Omics! Blog | Keith Robison gives his thoughts on the recent publication of the human genome sequencing paper focusing on Oxford Nanopore.

    Feb 7, 2018
  • Charles River Makes Investments In High-Throughput Screening Infrastructure

    Bio-IT World Brief | Charles River announced a new agreement which grants Charles River commercial access to AstraZeneca’s high-throughput screening and compound management infrastructure.

    Feb 6, 2018
  • Sequencing Human Genome With Pocket-Sized “Nanopore” Device

    NIH Director's Blog | A report in Nature Biotechnology highlights the latest advance in DNA sequencing: the sequencing and assembly of a human genome using a pocket-sized device.

    Feb 6, 2018
  • Gut Microbes Combine To Cause Colon Cancer, Study Suggests

    The New York Times | Two types of bacteria common in the gut may accelerate the growth of tumors, suggesting new possibilities for diagnosis and prevention.

    Feb 5, 2018
  • Despite Doubters, Moderna Raises $500 Million, Is Now Worth $7 Billion

    Forbes | Moderna Therapeutics, a biotechnology firm that is developing drugs that work on a genetic messaging system that is essentially to all living cells, has raised $500 million from a group of new and current investors.

    Feb 2, 2018
  • IBM Brings V100 GPUs To Its Cloud

    TOP500 | The popularity of NVIDIA's Tesla V100 GPUs got another boost this week with IBM's announcement that it has added them to its cloud offerings.

    Feb 2, 2018
  • Certara Acquires BaseCase, A Life Sciences Data Visualization Company

    Bio-IT World Brief | Certara today announced that it has acquired BaseCase, a data visualization software as a service company who has extensive Health Economics and Outcomes Research expertise and is actively working in the area of market access.

    Feb 1, 2018
  • The Doctor Responsible For Gene Therapy’s Greatest Setback Is Sounding A New Alarm

    MIT Technology Review | Toxic effects seen in animals raise questions about new gene therapies for children.

    Jan 31, 2018
  • Transpacific Biotech Startup Combines Asian Investors And Some Seriously Trendy Science Out Of MIT

    ENDPOINTS NEWS | Engine Biosciences plans to integrate AI and machine learning with hands-on lab work in drug development to create a whole new kind of drug development platform.

    Jan 31, 2018
  • A Biopharma Innovator's Wish List For President Trump

    STAT | In his first State of the Union address, the CEO of Alnylam Pharmaceuticals would like to hear President Trump address five key issues to foster the culture of innovation in the pharmaceutical industry.

    Jan 30, 2018
  • Will America Yield Its Position As The World’s Leader In Science And Technology?

    BostonGlobe | For the first time since World War II, America's primacy in science and technology is in jeopardy. Choices that the country makes today will determine whether it continues to reap the rewards that come from being at the cutting edge.

    Jan 29, 2018
  • Oxford Nanopore MinION Used To Produce Most Complete Human Genome

    Bio-IT World   A paper published today in Nature Biotechnology, reports Oxford Nanopore sequencing resulting in the most complete human genome ever assembled with a single technology.

    Jan 29, 2018
  • «
  • 321
  • 322
  • 323
  • 324
  • 325 (current)
  • 326
  • 327
  • 328
  • 329
  • 330
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy